News & Events

Philogen’s management team held a webinar on 29 September 2022 at 16:00 CEST
Philogen held a virtual briefing on 29 September 2022 at 10:00 ET / 15:00 BST / 16:00 CEST following the Board of Directors’ approval of the Half-Yearly Financial Report as of 30 June 2022.
Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, hosted a 1-hour live webcast and conference call to provide an update on Philogen clinical programs.
Please see the recording of the Webinar by clicking here